William Hurt

William Hurt is likely one of the last big names joining Ridley Scott's revision of the Robin Hood (current title) legend. HR reports that Hurt has joined the cast to play the Earl of Pembroke, William Marshall, a historical jouster of the era. He would be joining the feature cast which includes Russell Crowe, Cate Blanchett, Vanessa Redgrave, Mark Strong, Scott Grimes, Kevin Durand, Alan Doyle, Oscar Isaacs and Lea Seydoux.

Actress Marlee Matlin has written a new book in which she claims she was once in a physically abusive relationship with actor William Hurt. The pair co-starred in the film "Children of a Lesser God," for which Matlin won an Oscar in 1987 - she was the first deaf actress to win the award. Matlin and Hurt met while making the film and began a romantic relationship.

In her book, "I'll Scream Later," Matlin describes a turbulent and violent courtship and one abusive fight in which she claims Hurt threw her on a bed and ripped her clothes off while she sobbed, "No, no, no. Please Bill, no." In an interview on Access Hollywood, Matlin told host Nancy O'Dell, "I was always afraid ... of him, but i loved him." The two dated for two years. Matlin told O'Dell she had new bruises every day.

Provenge

Provenge, an immune therapy for certain forms of prostate cancer, provides statistically significant survival benefits for patients. We have actually known this for almost two years, but the last time around the FDA decided to ask for a larger study to verify the earlier results.

The new study, a Phase III trial named IMPACT, enrolled 512 patients with metastatic androgen-independent prostate cancer, a late-stage cancer than usually kills men in a few months. The trial showed that on average men lived over 20% longer when they had received the Provenge treatment. The exact statistical results will be presented at a medical conference shortly.

This is going to have a major impact on the entire biotechnology industry. If the FDA now approves Provenge, as expected, it will be the first approved immunotherapy. Immunotherapy research has been stifled by lack of funds because the FDA had never approved a therapy. When sales of Provenge begin, Dendreon should have the funds to both improve its therapy for prostate cancer and to create therapies for other forms of cancer.

Tucano T1 plane wrongly leading to overcooking the turbo during his training stint with air force last year, CNN has reported. This could have damaged the plane but it didn’t happen. Britain’s Daily Mail has repoeted the incident. “He flicked the wrong switch on shutdown and overcooked the turbo,” Watt told the paper. “I think he switched it back on.

It is a variant of Short Tucano T1. The Short Tucano was developed by the British Short Brothers company in order to meet a requirement to replace the Jet Provost as the basic trainer for the RAF, as laid down in Air Staff Target 412. It is an adaptation of the Embraer EMB-312 Tucano fitted with the more powerful 1,100 shp (820 kW) Garrett turboprop engine in place of the EMB-312’s 750 shp (560 kW) Pratt & Whitney Canada PT6 engine, to give higher climb performance.

(AGI) - Londra, 14 apr. - Ha premuto l'interruttore sbagliato e ha mandato in fumo il motore da un milione di sterline del suo aereo. La disavventura e' capitata lo scorso anno al principe William durante le 12 settimane di addestramento da pilota della Royal Air Force. Il primogenito del principe di Galles ha bruciato il motore del suo 'Short Tucano T1', turboelica da addestramento al combattimento derivato da un aereo brasiliano.